Original article| Volume 14, ISSUE 6, P833-841, June 2018

Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons



      Visceral obesity is associated with diabetogenic and atherogenic abnormalities, including insulin resistance and increased risk for cardiometabolic diseases and mortality. Rodent lipectomy studies have demonstrated a causal link between visceral fat and insulin resistance, yet human omentectomy studies have failed to replicate this metabolic benefit, perhaps owing to the inability to target the mesentery.


      We aimed to demonstrate that safe and effective removal of mesenteric fat could be achieved in obese insulin-resistant baboons using tissue liquefaction technology.


      Southwest National Primate Research Center, San Antonio, Texas.


      Tissue liquefaction technology has been developed to enable mesenteric visceral lipectomy (MVL) to be safely performed without disturbing the integrity of surrounding nerves and vessels in the mesentary. After an initial MVL optimization study (n = 3), we then performed MVL (n = 4) or sham surgery (n = 2) in a cohort of insulin-resistant baboons, and the metabolic phenotype was assessed via hyperinsulinemic-euglycemic clamps at baseline and 6 weeks later.


      MVL led to a 75% improvement in glucose disposal at 6-weeks follow-up (P = .01). Moreover, despite removing only an average of 430 g of mesenteric fat (~1% of total body mass), MVL led to a 14.4% reduction in total weight (P = .001). Thus, these data demonstrate that mesenteric fat can be safely targeted for removal by tissue liquefaction technology in a nonhuman primate, leading to substantial metabolic improvements, including reversal of insulin resistance and weight loss.


      These data provide the first demonstration of successful adipose tissue removal from the mesentery in a mammal. Importantly, we have demonstrated that when MVL is performed in obese, insulin-resistant baboons, insulin resistance is reversed, and significant weight loss occurs. Therefore, trials performing MVL in humans with abdominal obesity and related metabolic sequelae should be explored as a potential clinical tool to ameliorate insulin resistance and treat type 2 diabetes.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery for Obesity and Related Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Smith U.
        Abdominal obesity: a marker of ectopic fat accumulation.
        J Clin Invest. 2015; 125: 1790-1792
        • De Souza L.R.
        • Kogan E.
        • Berger H.
        • et al.
        Abdominal adiposity and insulin resistance in early pregnancy.
        J Obstet Gynaecol Can. 2014; 36: 969-975
        • Muzumdar R.
        • Allison D.B.
        • Huffman D.M.
        • et al.
        Visceral adipose tissue modulates mammalian longevity.
        Aging Cell. 2008; 7: 438-440
        • Gabriely I.
        • Ma X.H.
        • Yang X.M.
        • et al.
        Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?.
        Diabetes. 2002; 51: 2951-2958
        • Barzilai N.
        • She L.
        • Liu B.Q.
        • et al.
        Surgical removal of visceral fat reverses hepatic insulin resistance.
        Diabetes. 1999; 48: 94-98
        • Huffman D.M.
        • Barzilai N.
        Role of visceral adipose tissue in aging.
        Biochim Biophys Acta. 2009; 1790: 1117-1123
        • Johnson A.M.
        • Olefsky J.M.
        The origins and drivers of insulin resistance.
        Cell. 2013; 152: 673-684
        • Nseir W.
        • Artul S.
        • Nasrallah N.
        • Mograbi J.
        • Mahamid M.
        Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: effect of mild anemia.
        J Diabetes. 2016; 8: 502-507
        • Munoz-Rivas N.
        • Mendez-Bailon M.
        • Hernandez-Barrera V.
        • et al.
        Time trends in ischemic stroke among type 2 diabetic and non-diabetic patients: analysis of the Spanish national hospital discharge data (2003-2012).
        PLoS One. 2015; 10: e0145535
        • Albu J.B.
        • Heilbronn L.K.
        • Kelley D.E.
        • et al.
        Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes.
        Diabetes. 2010; 59: 627-633
        • Larson-Meyer D.E.
        • Newcomer B.R.
        • Heilbronn L.K.
        • et al.
        Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function.
        Obesity (Silver Spring). 2008; 16: 1355-1362
        • Del Corral P.
        • Bryan D.R.
        • Garvey W.T.
        • Gower B.A.
        • Hunter G.R.
        Dietary adherence during weight loss predicts weight regain.
        Obesity (Silver Spring). 2011; 19: 1177-1181
        • Klein S.
        • Fontana L.
        • Young V.L.
        • et al.
        Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease.
        N Engl J Med. 2004; 350: 2549-2557
        • Robles-Cervantes J.A.
        • Martinez-Abundis E.
        • Gonzalez-Ortiz M.
        • Cardenas-Camarena L.
        • Hernandez-Salazar E.
        • Olvera-Ozuna R.
        Behavior of insulin sensitivity and its relation to leptin and tumor necrosis factor-alpha in obese women undergoing liposuction: 6-month follow-up.
        Obes Surg. 2007; 17: 1242-1247
        • Ybarra J.
        • Blanco-Vaca F.
        • Fernandez S.
        • et al.
        The effects of liposuction removal of subcutaneous abdominal fat on lipid metabolism are independent of insulin sensitivity in normal-overweight individuals.
        Obes Surg. 2008; 18: 408-414
        • Thorne A.
        • Lonnqvist F.
        • Apelman J.
        • Hellers G.
        • Arner P.
        A pilot study of long-term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding.
        Int J Obes Relat Metab Disord. 2002; 26: 193-199
        • Csendes A.
        • Maluenda F.
        • Burgos A.M.
        A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy.
        Obes Surg. 2009; 19: 490-494
        • Dillard T.H.
        • Purnell J.Q.
        • Smith M.D.
        • et al.
        Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial.
        Surg Obes Relat Dis. 2013; 9: 269-275
        • Fabbrini E.
        • Tamboli R.A.
        • Magkos F.
        • et al.
        Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.
        Gastroenterology. 2010; 139: 448-455
        • Herrera M.F.
        • Pantoja J.P.
        • Velazquez-Fernandez D.
        • et al.
        Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: a randomized trial.
        Diabetes Care. 2010; 33: 1413-1418
        • Lima M.M.
        • Pareja J.C.
        • Alegre S.M.
        • et al.
        Visceral fat resection in humans: effect on insulin sensitivity, beta-cell function, adipokines, and inflammatory markers.
        Obesity (Silver Spring). 2013; 21: E182-E189
        • Neeland I.J.
        • Grundy S.M.
        • Li X.
        • Adams-Huet B.
        • Vega G.L.
        Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study.
        Nutr Diabetes. 2016; 6: e221
        • Daly M.K.P.A.
        Advanced and future phaco technology.
        in: Henderson B.A. Essentials of cataract surgery. SLACK Incorporated, Thorofare, NJ2007: 293
        • Barsam A.
        • Chandra A.
        • Bunce C.
        • Whitefield L.A.
        Prospective randomized controlled trial to compare the effect on the macula of AquaLase liquefaction and ultrasound phacoemulsification cataract surgery.
        J Cataract Refract Surg. 2008; 34: 991-995
        • Davis K.
        • Rasko Y.
        • Oni G.
        • Bills J.
        • Geissler P.
        • Kenkel J.M.
        Comparison of adipocyte viability and fat graft survival in an animal model using a new tissue liquefaction liposuction device vs standard Coleman method for harvesting.
        Aesthet Surg J. 2013; 33: 1175-1185
        • Mackool R.J.
        • Brint S.F.
        AquaLase: a new technology for cataract extraction.
        Curr Opin Ophthalmol. 2004; 15: 40-43
        • Borab Z.M.
        • Godek C.P.
        Tissue liquefaction liposuction for body contouring and autologous fat transfer: a retrospective review over 3 years.
        Eplasty. 2016; 16: e36
        • Comuzzie A.G.
        • Cole S.A.
        • Martin L.
        • et al.
        The baboon as a nonhuman primate model for the study of the genetics of obesity.
        Obes Res. 2003; 11: 75-80
        • DeFronzo R.A.
        • Tobin J.D.
        • Andres R.
        Glucose clamp technique: a method for quantifying insulin secretion and resistance.
        Am J Physiol. 1979; 237: E214-E223
        • Allsop J.R.
        • Wolfe R.R.
        • Burke J.F.
        The realiability of rates of glucose appearance in vivo calculated from constant tracer infusions.
        Biochem J. 1978; 172: 407-416
        • Chavez A.O.
        • Lopez-Alvarenga J.C.
        • Tejero M.E.
        • et al.
        Physiological and molecular determinants of insulin action in the baboon.
        Diabetes. 2008; 57: 899-908
        • Bastarrachea R.A.
        • Veron S.M.
        • Vaidyanathan V.
        • et al.
        Protocol for the measurement of fatty acid and glycerol turnover in vivo in baboons.
        J Lipid Res. 2011; 52: 1272-1280
        • Vaidyanathan V.
        • Bastarrachea R.A.
        • Higgins P.B.
        • et al.
        Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primates.
        Am J Physiol Endocrinol Metabol. 2012; 303: E624-E634
        • van As A.
        • Lombard F.
        Body surface area of the Chacma baboon (Papio ursinus).
        Growth. 1981; 45: 322-328
      1. Standards of medical care in diabetes–2010.
        Diabetes Care. 2010; 33: S11-S61
        • Kulkarni T.
        • Slaughter G.
        • Ego-Osuala C.
        • et al.
        Hyperglycemic challenge and distribution of adipose tissue in obese baboons.
        Int J Diabetol Vasc Dis Res. 2014; 2: (1)
        • Rissanen A.
        • Heliovaara M.
        • Knekt P.
        • Aromaa A.
        • Reunanen A.
        • Maatela J.
        Weight and mortality in Finnish men.
        J Clin Epidemiol. 1989; 42: 781-789
        • Allison D.B.
        • Fontaine K.R.
        • Manson J.E.
        • Stevens J.
        • VanItallie T.B.
        Annual deaths attributable to obesity in the United States.
        JAMA. 1999; 282: 1530-1538
        • Enzi G.
        • Cagnoni G.
        • Baritussio A.
        • et al.
        Effects of fat mass reduction by dieting and by lipectomy on carbohydrate metabolism in obese patients.
        Acta Diabetol Lat. 1979; 16: 147-156
        • Lambert E.V.
        • Hudson D.A.
        • Bloch C.E.
        • Koeslag J.H.
        Metabolic response to localized surgical fat removal in nonobese women.
        Aesthetic Plast Surg. 1991; 15: 105-110
        • Kim J.Y.
        • van de Wall E.
        • Laplante M.
        • et al.
        Obesity-associated improvements in metabolic profile through expansion of adipose tissue.
        J Clin Invest. 2007; 117: 2621-2637
        • Koh-Banerjee P.
        • Wang Y.
        • Hu F.B.
        • Spiegelman D.
        • Willett W.C.
        • Rimm E.B.
        Changes in body weight and body fat distribution as risk factors for clinical diabetes in US men.
        Am J Epidemiol. 2004; 159: 1150-1159
        • Yamaji T.
        • Iwasaki M.
        • Sasazuki S.
        • et al.
        Visceral fat volume and the prevalence of colorectal adenoma.
        Am J Epidemiol. 2009; 170: 1502-1511